# CASTLE BIOSCIENCES, INC. (CSTL) FY2026 Q2 Balance Sheet

- Company: CASTLE BIOSCIENCES, INC. (CSTL)
- Period: As of 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-07-30, accession number 0001628280-26-051052
- Page: https://plicit.ai/financials/cstl/fy2026-q2-balance-sheet
- Chart image: https://plicit.ai/charts/cstl-fy2026-q2-balance-sheet-sankey.png

## Chart details

Balance sheet as of 2026-06-30. The chart shows assets, liabilities and equity at that date.

- **Assets**: 561,177,000 US dollars
- **Current assets**: 341,100,000 US dollars
- **Non-current assets**: 220,077,000 US dollars
- **Liabilities**: 91,147,000 US dollars
- **Current liabilities**: 56,509,000 US dollars
- **Non-current liabilities**: 34,638,000 US dollars
- **Equity**: 470,030,000 US dollars
- **Marketable investment securities**: 204,689,000 US dollars
- **Cash and cash equivalents**: 62,116,000 US dollars
- **Accounts receivable, net**: 48,341,000 US dollars
- **Prepaid expenses and other current assets**: 15,374,000 US dollars
- **Inventory**: 10,580,000 US dollars
- **Property and equipment, net**: 104,682,000 US dollars
- **Goodwill and other intangible assets, net**: 95,096,000 US dollars
- **Operating lease assets**: 14,196,000 US dollars
- **Other assets – long-term**: 4,442,000 US dollars
- **Long-term accounts receivable, net**: 1,661,000 US dollars
- **Accrued compensation**: 26,893,000 US dollars
- **Other accrued and current liabilities**: 14,114,000 US dollars
- **Accounts payable**: 9,668,000 US dollars
- **Current portion of long-term debt**: 2,917,000 US dollars
- **Contingent consideration**: 1,500,000 US dollars
- **Operating lease liabilities**: 1,417,000 US dollars
- **Noncurrent operating lease liabilities**: 24,894,000 US dollars
- **Long-term debt**: 7,158,000 US dollars
- **Deferred tax liability**: 2,322,000 US dollars
- **Noncurrent finance lease liabilities**: 264,000 US dollars
- **Noncurrent portion of contingent consideration**: 0 US dollars
- **Additional paid-in capital**: 711,121,000 US dollars
- **Common stock, $0.001 par value per share; 200,000,000 shares authorized as of June 30, 2026 and December 31, 2025; 30,508,534 and 29,686,314 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively**: 31,000 US dollars
- **Preferred stock, $0.001 par value per share; 10,000,000 shares authorized as of June 30, 2026 and December 31, 2025; no shares issued and outstanding as of June 30, 2026 and December 31, 2025**: 0 US dollars
- **Accumulated deficit**: negative 240,866,000 US dollars
- **Accumulated other comprehensive (loss) income**: negative 256,000 US dollars
- **Gross equity (calculated)**: 711,152,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

### Chart connections

- Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
- Treasury shares and other negative equity contributions reduce equity.